GreyViews estimates that the market for endovascular therapy devices will exceed USD 4.94 billion by 2030. This is at a CAGR between 7.4% and 2030.

Endovascular Therapy Devices Market Size by Product Type (Thoracic Aortic Aneurysms Graft, Fenestrated EVAR, Percutaneous Endovascular Aneurysm Repair (EVAR), Aortic Stents, Self-Expanding Nitinol Stents and Others), By Application (Neurology, Cardiology, Pulmonary, Vascular and Others), By End -User (Research Institutes, Hospitals & Clinics and Others), Regions, Segmentation, and forecast till 2030.

Pune India, Jan. 06, 2023 (GLOBE NEWSWIRE) — The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa. These are the top regions in which the market is strongest. Market for endovascular therapy devices The company is in operation and expected to grow soon. Manufacturers and suppliers are involved in the Market for endovascular therapy devices They are found in many countries within the mentioned regions.

Get a Sample of This Report @ https://greyviews.com/reports/endovascular-therapy-devices-market/280/request-sample

This report gives a comprehensive understanding of market segments that have been created by combining prospects such as product type, end-user, region, and application. The following paragraphs discuss the market’s key drivers, challenges, opportunities and restraints.
These are the major players in the global market endovascular therapy devices market Medtronic, Japan Lifeline and Nellix are some of the others. Manufacturers seek to increase their market share in the wearable pregnancy devices market worldwide by expanding through current developments, mergers-and-acquisitions, product innovations, collaborations and partnerships, as well as joint ventures.
Endovascular therapy involves the insertion of flexible tubes, stents, and catheters into blood vessels for the purpose supplying blood to patients or withdrawing medication from their bloodstream. As endovascular treatments devices become more widely accepted and recognized, the market will grow at an expected healthy pace. There are many options for endovascular therapy devices, including those that require less intervention, are less painful, don’t require hospitalizations, have shorter recovery times, and are easier to use. Innovative medical device design will drive growth in the market, both in developing and developed countries. Endovascular devices can be used for chemotherapy and blood transfusions. The market for endovascular treatments is expected to grow as more clinical evidence supports the efficacy of endovascular procedures in the treatment of acute ischemic strokes, and aortic surgery. The market is constrained by the high price of endovascular surgery, a lack of awareness in low-income countries and a shortage of qualified surgeons. With new advancements in stent technology as well as an increase in interventionist expertise, the global market for endovascular therapy devices will continue to grow.

Ask before you buy this report @  https://greyviews.com/inquiry/280

Scope of Endovascular Therapy Devices market report:

Segmentation Analysis

Percutaneous Endovascular Aneurysm Repair will be the fastest-growing segment by 2022. 

This product segment comprises thoracic aortic and fenestrated EVAR, percutaneous aneurysm repairs (EVAR), fenestrated EVAR and percutaneous endovascular aortic aneurysm graft. The segment of percutaneous endovascular aeurysm repair is expected to grow at the fastest rate over the forecast period. The endovascular aortic repair (EVAR), a popular and safe procedure for repairing abdominal aortic aeurysms, is a highly effective, reliable, and well-respected option. Percutaneous access methods can also be used instead of surgical cutdowns to treat abdominal aortic and femoral aneurysms. PEVAR surgery can be used for large abdominal aortic aneurysms that are expanding rapidly, bleeding, or leaking.

The fastest-growing segment of 2022 will be cardiology. 

This application segment covers neurology, cardiology and pulmonary. The highest growth rate is expected for the cardiology segment during the forecast period. Cardiovascular disease will be the fastest growing segment of endovascular treatments devices during the forecast period. Endovascular therapy uses internal treatment to treat cardiovascular diseases. Endovascular therapy devices allow for the management of a wide range of cardiac and vascular conditions previously only possible with invasive surgery.

Hospitals & clinics are expected to be the fastest-growing segment in 2022. 

The end-user segment includes clinics, hospitals & clinics and others. The hospitals & clinics segment is expected to witness the highest growth rate during the forecast period. Hospitals and clinics will see significant growth over the forecast period. This will make them a major contributor to the market’s growth. Hospitals and clinics provide advanced care for their patients, and may even reimburse patients for certain procedures.

Regional Analysis           

The country and key regions are analyzed in detail. Some of the countries that have been analyzed in the endovascular treatment devices market are the USA, Canada Mexico, France, Germany, France and Spain.

North America accounted for a large portion of the increase. Endovascular therapy has seen significant growth in this region due to the liberalization of healthcare and trade-related effects. Market growth for Endovascular Therapy Devices will be driven by the rise in obesity, diet, and the presence of major manufacturers in the area. The market players will likely take strategic initiatives in order to grow the market.

Analyse of Country

The market for endovascular therapy devices in Germany was worth USD 0.27 billion in 2022. It is projected to grow to USD 129.37 by 2030 at a CAGR 7.5% between 2023 and 2030.
This region is expected to have a strong healthcare infrastructure that will help drive the demand for endovascular therapies devices. The region has seen technological advancements that have transformed revascularization strategies since open surgery.

China’s endovascular therapy devices market size was valued at USD 0.17 billion in 2022 and is expected to reach USD 138.34 billion by 2030, at a CAGR of 7.8% from 2023 to 2030.
Rapid technological development, the creation of new products and high rates of CVDs are just a few of the reasons for the market’s growth in the country.

India’s market share for endovascular therapies devices in India was USD 0.138 million in 2022. By 2030, it is expected to be USD 0.249illion. This will represent a CAGR 7.7% between 2023 and 2030.
Endovascular treatment devices have seen significant revenue growth due to medical advances. This has allowed the industry to continue to expand and provide more opportunities for growth.
Impact of Covid-19
Covid-19 had a significant impact on nearly all industries such as electronics and semiconductors, automotive manufacturing, and so forth. However, many technology companies have seen an increase in revenue because of significant consumer preferences for technological services. A pandemic in the Philippines has seen significant growth in technology both in developed and developing nations.

Additionally, this market has seen a significant increase in demand from the health sector as a result of increasing cases of cardiovascular diseases. This is driving the market growth across countries.

Purchase Now for the Full Report @ https://greyviews.com/checkout/280/single_user_license

Contact us

Rocky Shah

GreyViews

Pune India

Phone: (+44) 162-237-1047

Email: [email protected]

Web: https://greyviews.com/

Follow us: LinkedIn | Twitter

Check out these Related Reports

Hemodynamic Monitoring system Market Size by System (Invasive, Minimally Invasive, and Non-invasive Monitoring System), By End-User Catheterization Laboratories Hospitals and Other), Regions, Segmentation and Projection until 2030

https://greyviews.com/reports/hemodynamic-monitoring-system-market/372

Market size for Dermatology Lasers by Type (Gem Laser Machines, Gas Laser Machines and Semiconductor Laser Machines), By Application (Beauty & Skin Diseases), Regions Segmentation and Projections till 2030

https://greyviews.com/reports/dermatology-lasers-market/370

Pharmaceutical Glass Packaging Market Size By Product (Bottles, Vials, Cartridges & Syringes, and Ampoules), By Drug Type (Branded, Biologic and Generic), Regions, Segmentation, and Projection till 2030

https://greyviews.com/reports/pharmaceutical-glass-packaging-market/367

Pharmaceuticals Preservative Market Share By Source (Natural Pharmaceuticals Preservative Agents & Synthetic Pharmaceuticals Preservative Agents), by Function (Antioxidants Pharmaceuticals Preservative Agents), Antimicrobial Pharmaceuticals Preservative Agents, Chelating Pharmaceuticals Preservative Agents), regions, segmentation, and projection till 2030

https://greyviews.com/reports/pharmaceuticals-preservative-market/361

Ophthalmic Drugs Market Size By Drug Class (Anti-Inflammatory, Anti-Glaucoma, Anti-VEGF Agents, Antiallergy, and Others), By Disease (Glaucoma, Eye Allergy, Eye Infection, Uveitis, Dry Eye, Retinal Disorders, and Others), By Dosage Form (Eye Solutions & Suspensions, Eye Drops, Gels, Capsules and Tablets, and Ointments), Regions, Segmentation, and Projection till 2030

https://greyviews.com/reports/ophthalmic-drugs-market/357

The Neurosurgery Surgical Tools Market Size by Tools Type (Drills, Reamers and Other), By Power Types (Pneumatic, Electrical, and Battery Powered), Regions and Segmentation and Projection until 2030

https://greyviews.com/reports/neurosurgery-surgical-power-tools-market/356

Neonatal Phototherapy Devices Market Share By Light Source (Quartz halogen lamps and gas discharge tubes, Fluorescent lamps and fluorescent lamps (FL), By Configuration (Mobile and Fixed devices), By End-User(Hospitals and Neonatal clinics), by Regions, Segmentation and Projection until 2030

https://greyviews.com/reports/neonatal-phototherapy-devices-market/355

Market Size of Minimally Invasive Cataract Surgery Equipments by Type (Stand Alone Glaucoma or Phacoemulsification and Glaucoma in conjunction with Cataract. Femtosecond Laser Surgery. Extracapsular Cataract Extraction Surgery.

https://greyviews.com/reports/minimally-invasive-cataract-surgery-devices-market/354

Healthcare Cold Chain Logistics Market Size by Type (Vaccines, Biopharmaceuticals, Clinical Trial Materials and Other), By Services (Transportation, Storage and Other), Regions, Segmentation and Projection until 2030

https://greyviews.com/reports/healthcare-cold-chain-logistics-market/353

Market Size for Disposable Syringes By Product (Conventional Syringes or Safety Syringes), And By Application (Immunization injections and Therapeutic injections), Regions, Segmentation and Projection until 2030

https://greyviews.com/reports/disposable-syringes-market/351